Viewing Company
Company Name:
CHELSEA THERAPEUTICS INTERNATIONAL, LTD.
CIK:
1333763
Phone:
None
Fiscal Year End:
None
Entity Type:
SIC:
-
Category Type:
Entity Name:
None
First Filing Date:
2011-07-27
Last Filing Date:
2014-05-09
SEC Filings
| Start | End | Frame | Filed | ACCN | Value | View |
|---|---|---|---|---|---|---|
| 2012-01-01 | 2012-03-31 | CY2012Q1 | 2012-05-01 | 0001193125-12-200720 | $ 22,145,220 | View |
| 2008-01-01 | 2007-01-31 | CY2006Q4I | 2012-03-07 | 0001193125-12-101178 | $ 433,750 | View |
| 2011-01-01 | 2007-01-31 | CY2011Q3I | 2011-11-02 | 0001193125-11-292949 | $ 433,750 | View |
| 2011-01-01 | 2007-01-31 | CY2011Q2I | 2011-07-27 | 0001193125-11-198939 | $ 433,750 | View |
| 2012-04-01 | 2012-06-30 | CY2011Q2 | 2012-08-07 | 0001144204-12-043342 | $ 67,040,569 | View |
| 2012-07-02 | 2012-09-30 | CY2011Q3 | 2012-11-07 | 0001144204-12-060045 | $ 67,040,569 | View |
| 2012-01-01 | 2012-12-31 | CY2010 | 2013-03-07 | 0001144204-13-013609 | $ 66,892,982 | View |
| 2013-01-01 | 2013-03-31 | CY2012Q1 | 2013-05-01 | 0001144204-13-025705 | $ 67,075,779 | View |
| 2013-04-01 | 2013-06-30 | CY2013Q2 | 2013-08-06 | 0001144204-13-043270 | $ 67,094,460 | View |
| 2013-07-01 | 2013-09-30 | CY2013Q3 | 2013-11-05 | 0001144204-13-058837 | $ 67,208,361 | View |
| 2013-01-01 | 2013-12-31 | CY2013 | 2014-03-11 | 0001144204-14-014836 | $ 68,825,944 | View |
| 2014-01-01 | 2014-03-31 | CY2014Q1 | 2014-05-09 | 0001144204-14-029111 | $ 78,438,816 | View |
SEC Facts By Type
| Type | Name | Description | View |
|---|---|---|---|
| dei | Entity Common Stock, Shares Outstanding | Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. | View |
| us-gaap | Cash and Cash Equivalents, Fair Value Disclosure | Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Earnings Per Share, Basic and Diluted | The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | View |
| us-gaap | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. | View |
| us-gaap | Payments to Acquire Intangible Assets | The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. | View |
| us-gaap | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. | View |
| us-gaap | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. | View |
| us-gaap | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. | View |
| us-gaap | Research and Development Expense (Excluding Acquired in Process Cost) | The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. | View |
| us-gaap | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | Cumulative net losses reported during the development stage. | View |
| dei | Entity Public Float | The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. | View |
| invest | Investment Warrants, Exercise Price | Exercise price of the warrants. | View |
| us-gaap | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accrued Bonuses, Current | Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services. | View |
| us-gaap | Additional Paid in Capital | Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. | View |
| us-gaap | Share-based Payment Arrangement, Expense | Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. | View |
| us-gaap | Assets | Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Assets, Current | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | Number of shares of equity interests issued or issuable to acquire entity. | View |
| us-gaap | Capitalized Computer Software, Gross | Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software. | View |
| us-gaap | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Payments for Restructuring | Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation. | View |
| us-gaap | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. | View |
| us-gaap | Cash and Cash Equivalents, Period Increase (Decrease) | Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. | View |
| us-gaap | Cash, FDIC Insured Amount | The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. | View |
| us-gaap | Class of Warrant or Right, Outstanding | Number of warrants or rights outstanding. | View |
| us-gaap | Common Stock, Capital Shares Reserved for Future Issuance | Aggregate number of common shares reserved for future issuance. | View |
| us-gaap | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | View |
| us-gaap | Common Stock, Share Subscribed but Unissued, Subscriptions Receivable | Amount of subscription receivable from investors who have been allocated common stock. | View |
| us-gaap | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | View |
| us-gaap | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | View |
| us-gaap | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | View |
| us-gaap | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. | View |
| us-gaap | Debt Conversion, Converted Instrument, Amount | "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." | View |
| us-gaap | Debt Conversion, Converted Instrument, Shares Issued | "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or payments in the period." | View |
| us-gaap | Deferred Tax Assets, Gross | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | View |
| us-gaap | Deferred Tax Assets, Inventory | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory. | View |
| us-gaap | Deferred Tax Assets, Net of Valuation Allowance | Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards. | View |
| us-gaap | Deferred Tax Assets, Other | Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other. | View |
| us-gaap | Deferred Tax Assets, Valuation Allowance | Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. | View |
| us-gaap | Defined Contribution Plan, Maximum Annual Contribution Per Employee, Amount (Deprecated 2013-01-31) | Maximum amount per employee, by the terms of the plan, that the employer may contribute to a defined contribution plan. | View |
| us-gaap | Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent (Deprecated 2013-01-31) | Maximum percentage of employee gross pay, by the terms of the plan, that the employer may contribute to a defined contribution plan. | View |
| us-gaap | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan. | View |
| us-gaap | Deposit Liabilities, Accrued Interest | Amount of accrued but unpaid interest on deposit liabilities. | View |
| us-gaap | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Percent | Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | Percentage of domestic federal statutory tax rate applicable to pretax income (loss). | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). | View |
| us-gaap | Employee-related Liabilities, Current | Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | Amount of cost not yet recognized for nonvested award under share-based payment arrangement. | View |
| us-gaap | Equity Issuance, Amount Per Share (Deprecated 2012-01-31) | The amount per share assigned to the consideration received for equity securities issued by a development stage enterprise during a specific stock issuance since its inception. | View |
| us-gaap | Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) | Amount per share or per unit assigned to the consideration received of equity securities issued for development stage entities. | View |
| us-gaap | Furniture and Fixtures, Gross | Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases. | View |
| us-gaap | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property. | View |
| us-gaap | Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) | The gains (losses) included in results of operations resulting from the sale or disposal of property, plant and equipment, which do not qualify for treatment as discontinued operations. This item does not include any gain (loss) recognized on the sale of oil and gas property or timber property. | View |
| us-gaap | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. | View |
| us-gaap | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. | View |
| us-gaap | Increase (Decrease) in Employee Related Liabilities | The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. | View |
| us-gaap | Increase (Decrease) in Other Accrued Liabilities | The increase (decrease) during the reporting period in other expenses incurred but not yet paid. | View |
| us-gaap | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. | View |
| us-gaap | Increase (Decrease) in Restructuring Reserve | The increase (decrease) during the period in the carrying amount (including both current and noncurrent portions of the accrual) of the liability pertaining to the exit from or disposal of business activities or restructuring pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination and to asset retirement obligations. | View |
| us-gaap | Increase (Decrease) in Security Deposits | The increase (decrease) during the reporting period in security deposits. | View |
| us-gaap | Intangible Assets, Net (Excluding Goodwill) | Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. | View |
| us-gaap | Interest Expense | Amount of the cost of borrowed funds accounted for as interest expense. | View |
| us-gaap | Interest Payable | Amount of interest payable on debt, including, but not limited to, trade payables. | View |
| us-gaap | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. | View |
| us-gaap | Issuance of Stock and Warrants for Services or Claims | Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. | View |
| us-gaap | Leasehold Improvements, Gross | Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement. | View |
| us-gaap | Liabilities | Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. | View |
| us-gaap | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. | View |
| us-gaap | Line of Credit Facility, Increase (Decrease), Net | Amount of increase (decrease) of the credit facility. | View |
| us-gaap | Loans Payable | Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer). | View |
| us-gaap | Noncontrolling Interest, Ownership Percentage by Parent | The parent entity's interest in net assets of the subsidiary, expressed as a percentage. | View |
| us-gaap | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. | View |
| us-gaap | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. | View |
| us-gaap | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. | View |
| us-gaap | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. | View |
| us-gaap | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | View |
| us-gaap | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | View |
| us-gaap | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | View |
| us-gaap | Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Warrants Issued | "The number of warrants issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." | View |
| us-gaap | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. | View |
| us-gaap | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. | View |
| us-gaap | Other Accrued Liabilities, Current | Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. | View |
| us-gaap | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. | View |
| us-gaap | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. | View |
| us-gaap | Paid-in-Kind Interest | Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method. | View |
| us-gaap | Payments for (Proceeds from) Investments | The net cash paid (received) associated with the acquisition or disposal of all investments, including securities and other assets. | View |
| us-gaap | Payments to Acquire Investments | The cash outflow associated with the purchase of all investments (debt, security, other) during the period. | View |
| us-gaap | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | View |
| us-gaap | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | View |
| us-gaap | Preferred Stock, Shares Issued | Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. | View |
| us-gaap | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | View |
| us-gaap | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. | View |
| us-gaap | Proceeds from Contributions from Affiliates | The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership. | View |
| us-gaap | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. | View |
| us-gaap | Proceeds from Issuance or Sale of Equity | The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. | View |
| us-gaap | Proceeds from Legal Settlements | Cash received for the settlement of litigation during the current period. | View |
| us-gaap | Proceeds from Sale of Productive Assets | The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets. | View |
| us-gaap | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. | View |
| us-gaap | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. | View |
| us-gaap | Property, Plant and Equipment, Gross | Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. | View |
| us-gaap | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. | View |
| us-gaap | Recapitalization Costs | Amount of recapitalization costs for professional fees associated with restructuring debt and equity mixture that do not qualify for capitalization. | View |
| us-gaap | Research and Development Expense | The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Number of options outstanding, including both vested and non-vested options. | View |
| us-gaap | Restructuring Charges | Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. | View |
| us-gaap | Restructuring Reserve | Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan. | View |
| us-gaap | Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) | Amount of (expense) reversal of expense related to a previously accrued restructuring cost liability. Excludes adjustments for costs incurred, costs settled, and foreign currency translation adjustments. | View |
| us-gaap | Restructuring Reserve, Settled With Cash (Deprecated 2013-01-31) | Amount of cash paid in the period to fully or partially settle a specified, previously accrued type of restructuring cost. | View |
| us-gaap | Revenue from Grants (Deprecated 2018-01-31) | Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements. | View |
| us-gaap | Selling and Marketing Expense | The aggregate total amount of expenses directly related to the marketing or selling of products or services. | View |
| us-gaap | Share-based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | The risk-free interest rate assumption that is used in valuing an option on its own shares. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | Number of shares authorized for issuance under share-based payment arrangement. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | Weighted average price of options that were either forfeited or expired. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | Net number of share options (or share units) granted during the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Gross number of share options (or share units) granted during the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) | Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | Number of shares issued under share-based payment arrangement. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | Weighted average price at which option holders acquired shares when converting their stock options into shares. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. | View |
| us-gaap | Short-term Investments | Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. | View |
| us-gaap | Purchase Commitment, Remaining Minimum Amount Committed (Deprecated 2013-01-31) | The floor amount as of the balance sheet date that the entity must expend to satisfy the terms of disclosed arrangements (excluding long-term commitments) in which the entity has agreed to expend funds to procure goods or services from one or more suppliers, other than under a long-term purchase commitment or an unconditional purchase obligation. | View |
| us-gaap | Stockholders' Equity Attributable to Parent | Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. | View |
| us-gaap | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | View |
| us-gaap | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. | View |
| us-gaap | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. | View |
| us-gaap | Debt Securities, Trading, and Equity Securities, FV-NI | Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). | View |
| us-gaap | Warrants and Rights Outstanding | Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic and Diluted | Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). | View |
Chart of Accounts => Accounts
| Name | View |
|---|---|
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | View |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | View |
| Prepaid Expense and Other Assets, Current | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | View |
| Accounts Payable, Current | View |
| Accrued Bonuses, Current | View |
| Accrued Liabilities, Current | View |
| Additional Paid in Capital | View |
| Share-based Payment Arrangement, Expense | View |
| Assets | View |
| Assets, Current | View |
| Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | View |
| Capitalized Computer Software, Gross | View |
| Cash and Cash Equivalents, at Carrying Value | View |
| Cash and Cash Equivalents, Fair Value Disclosure | View |
| Cash and Cash Equivalents, Period Increase (Decrease) | View |
| Cash, FDIC Insured Amount | View |
| Class of Warrant or Right, Outstanding | View |
| Common Stock, Capital Shares Reserved for Future Issuance | View |
| Common Stock, Par or Stated Value Per Share | View |
| Common Stock, Share Subscribed but Unissued, Subscriptions Receivable | View |
| Common Stock, Shares Authorized | View |
| Common Stock, Shares, Issued | View |
| Common Stock, Shares, Outstanding | View |
| Common Stock, Value, Issued | View |
| Debt Conversion, Converted Instrument, Amount | View |
| Debt Conversion, Converted Instrument, Shares Issued | View |
| Deferred Tax Assets, Gross | View |
| Deferred Tax Assets, Inventory | View |
| Deferred Tax Assets, Net of Valuation Allowance | View |
| Deferred Tax Assets, Operating Loss Carryforwards, Domestic | View |
| Deferred Tax Assets, Operating Loss Carryforwards, State and Local | View |
| Deferred Tax Assets, Other | View |
| Deferred Tax Assets, Valuation Allowance | View |
| Defined Contribution Plan, Maximum Annual Contribution Per Employee, Amount (Deprecated 2013-01-31) | View |
| Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent (Deprecated 2013-01-31) | View |
| Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | View |
| Deposit Liabilities, Accrued Interest | View |
| Depreciation, Depletion and Amortization | View |
| Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | View |
| Earnings Per Share, Basic and Diluted | View |
| Effective Income Tax Rate Reconciliation, Percent | View |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | View |
| Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | View |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | View |
| Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | View |
| Employee-related Liabilities, Current | View |
| Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | View |
| Equity Issuance, Amount Per Share (Deprecated 2012-01-31) | View |
| Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) | View |
| Furniture and Fixtures, Gross | View |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | View |
| Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) | View |
| General and Administrative Expense | View |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | View |
| Increase (Decrease) in Employee Related Liabilities | View |
| Increase (Decrease) in Other Accrued Liabilities | View |
| Increase (Decrease) in Prepaid Expense and Other Assets | View |
| Increase (Decrease) in Restructuring Reserve | View |
| Increase (Decrease) in Security Deposits | View |
| Intangible Assets, Net (Excluding Goodwill) | View |
| Interest Expense | View |
| Interest Payable | View |
| Investment Income, Interest | View |
| Issuance of Stock and Warrants for Services or Claims | View |
| Leasehold Improvements, Gross | View |
| Liabilities | View |
| Liabilities and Equity | View |
| Line of Credit Facility, Increase (Decrease), Net | View |
| Loans Payable | View |
| Noncontrolling Interest, Ownership Percentage by Parent | View |
| Net Cash Provided by (Used in) Financing Activities | View |
| Net Cash Provided by (Used in) Financing Activities, Continuing Operations | View |
| Net Cash Provided by (Used in) Investing Activities | View |
| Net Cash Provided by (Used in) Investing Activities, Continuing Operations | View |
| Net Cash Provided by (Used in) Operating Activities | View |
| Net Cash Provided by (Used in) Operating Activities, Continuing Operations | View |
| Net Income (Loss) Attributable to Parent | View |
| Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Warrants Issued | View |
| Operating Expenses | View |
| Operating Income (Loss) | View |
| Other Accrued Liabilities, Current | View |
| Other Assets, Noncurrent | View |
| Other Nonoperating Income (Expense) | View |
| Paid-in-Kind Interest | View |
| Payments for (Proceeds from) Investments | View |
| Payments for Restructuring | View |
| Payments of Stock Issuance Costs | View |
| Payments to Acquire Intangible Assets | View |
| Payments to Acquire Investments | View |
| Payments to Acquire Property, Plant, and Equipment | View |
| Preferred Stock, Par or Stated Value Per Share | View |
| Preferred Stock, Shares Authorized | View |
| Preferred Stock, Shares Issued | View |
| Preferred Stock, Shares Outstanding | View |
| Preferred Stock, Value, Issued | View |
| Prepaid Expense, Current | View |
| Proceeds from Contributions from Affiliates | View |
| Proceeds from Issuance of Common Stock | View |
| Proceeds from Issuance or Sale of Equity | View |
| Proceeds from Legal Settlements | View |
| Proceeds from Sale of Productive Assets | View |
| Proceeds from Stock Options Exercised | View |
| Proceeds from Warrant Exercises | View |
| Property, Plant and Equipment, Gross | View |
| Property, Plant and Equipment, Net | View |
| Recapitalization Costs | View |
| Research and Development Expense | View |
| Research and Development Expense (Excluding Acquired in Process Cost) | View |
| Restructuring Charges | View |
| Restructuring Reserve | View |
| Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) | View |
| Restructuring Reserve, Settled With Cash (Deprecated 2013-01-31) | View |
| Revenue from Grants (Deprecated 2018-01-31) | View |
| Selling and Marketing Expense | View |
| Share-based Payment Arrangement, Noncash Expense | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | View |
| Short-term Investments | View |
| Purchase Commitment, Remaining Minimum Amount Committed (Deprecated 2013-01-31) | View |
| Stockholders' Equity Attributable to Parent | View |
| Stock Issued During Period, Shares, New Issues | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | View |
| Stock Issued During Period, Value, New Issues | View |
| Stock Issued During Period, Value, Stock Options Exercised | View |
| Debt Securities, Trading, and Equity Securities, FV-NI | View |
| Warrants and Rights Outstanding | View |
| Weighted Average Number of Shares Outstanding, Basic and Diluted | View |